# Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC

Source: https://onco.cc/trials/nct07554846/  
OnCo record `nct07554846` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in lung cancer, run by Fudan University, now recruiting.

## Summary

Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC is a phase 3, randomised interventional study registered as NCT07554846 by Fudan University, with a registry enrolment figure of 759 participants, started 2026-05-01 and due to reach its primary completion in 2030-05-01. Interventions recorded: Peroperative immunotherapy; Neoadjuvant immunotherapy; Adjuvant immunotherapy. Conditions listed: Resectable Stage II-IIIa NSCLC. Primary outcome: 3-year events-free survival (EFS) rate. Lung eligibility wording from the registry: "Subjects with resectable stage II-IIIA non-small cell lung cancer (according to the AJCC 8th edition), without EGFR/ALK sensitive mutations, confirmed by histology or pathology;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Also known as: ECTOP-1030
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT07554846
- Phase: 3
- Setting: A Randomized, Open-label, Multicenter Phase III Clinical Trial Comparing Perioperative Immunotherapy to Adjuvant Immunotherapy or Neoadjuvant Immunotherapy With Toripalimab in Resectable Stage II-IIIA Non-small Cell Lung Cancer (ECTOP-1030)
- Sponsor: Fudan University
- Enrolled: 759

## Sources

- ClinicalTrials.gov NCT07554846: https://clinicaltrials.gov/study/NCT07554846

## Connected records

- cancers: [Resectable stage I to III non-small-cell lung cancer](https://onco.cc/cancers/resectable-nsclc/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07554846.json